Articles with category: Article
About a drug: Cocaine
Portrayed as one of the most glamorous drugs, cocaine has made a huge splash in pop culture and left a huge scar on South America.
Q&A: Russell Brand
On the tenth anniversary of his recovery, comedian Russell Brand invited Matters of Substance backstage to the final show of his Australia and New Zealand tour.
Mythbusters: There is no such thing as cannabis withdrawal
Cannabis doesn't have the physical symptoms of withdrawl that other drugs have, but it does have it.
Viewpoints: Should unregistered naltrexone implants be used to treat opioid dependence?
Naltrexone is still untested. Should we allow it to be used as an opiod blocker? Viewpoints takes a look.
The cost of our convictions
How much does imprisoning young New Zealanders for minor drug offences cost us?
Where now for opponents of cannabis law reform?
Steve Rolles considers how recent cannabis law reform victories are reshaping the landscape of the oldest debate in drug policy.
Why the UN needs civil society
Yury Fedotov, the Executive Director of the United Nations Office of Drugs and Crime writes about the important role of civil society.
How we see things from our front gate
Russell School's success in reducing harm from a poorly managed local liquor store shows what can be achieved when communities engage and mobilise.
Putting the ‘bi’ into binge
Emma Hart suggests there’s a reason why bisexual people binge drink more than straight dudes and dudesses and that the biphobic media aren’t helping the situation at all.
Crime and punishment:
Russia’s treatment of its addicted citizens is characterised by cruelty. They are denied medicine, beaten, raped and tortured. Yet according to the propoganda these are the luckiest drug addicts on the planet.
The Drug War in retreat?
Are we witnessing the beginning of the end for the global War on Drugs? Attacks on drug war ideology are coming from all quarters, argues Russell Brown, to the point where the United Nations has been forced to act. But how much regard the U
Future drugs
Rob Zorn talks with a few drug policy experts about what the world can expect to see over the next few years.